3.連結財務諸表及び主な注記
(1)連結財政状態計算書
| | | (単位:百万円) |
| 前連結会計年度 (2024年12月31日) | | 当連結会計年度 (2025年12月31日) |
資産 | | | |
流動資産 | | | |
現金及び現金同等物 | 426,173 | | 534,645 |
売上債権及びその他の債権 | 515,289 | | 565,990 |
棚卸資産 | 298,292 | | 374,323 |
未収法人所得税 | 3,531 | | 4,326 |
その他の金融資産 | 31,905 | | 34,354 |
その他の流動資産 | 91,780 | | 105,712 |
(小計) | 1,366,972 | | 1,619,352 |
売却目的で保有する資産 | - | | 2,653 |
流動資産合計 | 1,366,972 | | 1,622,006 |
非流動資産 | | | |
有形固定資産 | 628,544 | | 696,808 |
のれん | 449,464 | | 509,984 |
無形資産 | 544,247 | | 574,134 |
持分法で会計処理されている投資 | 314,780 | | 359,036 |
その他の金融資産 | 206,272 | | 223,003 |
繰延税金資産 | 205,700 | | 185,009 |
その他の非流動資産 | 23,267 | | 27,580 |
非流動資産合計 | 2,372,278 | | 2,575,556 |
資産合計 | 3,739,251 | | 4,197,562 |
| | | (単位:百万円) |
| 前連結会計年度 (2024年12月31日) | | 当連結会計年度 (2025年12月31日) |
負債及び資本 | | | |
負債 | | | |
流動負債 | | | |
仕入債務及びその他の債務 | 219,996 | | 225,562 |
社債及び借入金 | 7,350 | | 39,150 |
リース負債 | 21,146 | | 21,906 |
その他の金融負債 | 4,387 | | 10,215 |
未払法人所得税 | 29,250 | | 39,895 |
引当金 | 1,242 | | 1,077 |
契約負債 | 13,952 | | 11,331 |
その他の流動負債 | 335,338 | | 399,972 |
流動負債合計 | 632,664 | | 749,112 |
| | | |
非流動負債 | | | |
社債及び借入金 | 87,275 | | 87,856 |
リース負債 | 73,612 | | 79,063 |
その他の金融負債 | 53,127 | | 68,045 |
未払法人所得税 | 1,584 | | 2,109 |
退職給付に係る負債 | 12,564 | | 12,574 |
引当金 | 3,766 | | 3,944 |
契約負債 | 35,361 | | 26,025 |
繰延税金負債 | 28,801 | | 33,593 |
その他の非流動負債 | 32,327 | | 35,474 |
非流動負債合計 | 328,421 | | 348,688 |
負債合計 | 961,085 | | 1,097,801 |
| | | |
資本 | | | |
親会社の所有者に帰属する持分 | | | |
資本金 | 81,690 | | 81,690 |
資本剰余金 | 478,486 | | 428,044 |
自己株式 | △67,398 | | △85,186 |
利益剰余金 | 1,904,404 | | 2,205,740 |
その他の資本の構成要素 | 336,397 | | 403,154 |
親会社の所有者に帰属する持分合計 | 2,733,580 | | 3,033,444 |
非支配持分 | 44,584 | | 66,317 |
資本合計 | 2,778,165 | | 3,099,761 |
負債及び資本合計 | 3,739,251 | | 4,197,562 |
E2118345780大塚ホールディングス株式会社Otsuka Holdings Co.,Ltd.通期第3号参考様式 [IFRS](連結)IFRStrueCTECTE2025-01-012025-12-31FY2025-12-312024-01-012024-12-312024-12-311falsefalsefalse457802024-01-012024-12-31jpcrp_cor:ReportableSegmentsMember457802024-01-012024-12-31tse-acediffr-45780:PharmaceuticalsReportableSegmentMember457802024-01-012024-12-31tse-acediffr-45780:NutraceuticalsReportableSegmentMember457802024-01-012024-12-31tse-acediffr-45780:ConsumerProductsReportableSegmentMember457802024-01-012024-12-31tse-acediffr-45780:OtherReportableSegmentMember457802024-01-012024-12-31jpcrp_cor:ReconcilingItemsMember457802023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember457802023-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember457802023-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember457802023-12-31jpigp_cor:RetainedEarningsIFRSMember457802023-12-31jpigp_cor:TreasurySharesIFRSMember457802023-12-31jpigp_cor:CapitalSurplusIFRSMember457802023-12-31jpigp_cor:ShareCapitalIFRSMember457802025-12-31jpigp_cor:NonControllingInterestsIFRSMember457802025-12-31457802025-01-012025-12-31457802025-01-012025-12-31jpigp_cor:CapitalSurplusIFRSMember457802025-01-012025-12-31jpigp_cor:ShareCapitalIFRSMember457802024-12-31jpigp_cor:NonControllingInterestsIFRSMember457802024-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember457802024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember457802024-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember457802024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember457802024-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember457802024-12-31457802024-01-012024-12-31457802023-12-31457802026-02-13457802025-01-012025-12-31jpcrp_cor:ReportableSegmentsMember457802025-01-012025-12-31tse-acediffr-45780:PharmaceuticalsReportableSegmentMember457802025-01-012025-12-31tse-acediffr-45780:NutraceuticalsReportableSegmentMember457802025-01-012025-12-31tse-acediffr-45780:ConsumerProductsReportableSegmentMember457802025-01-012025-12-31tse-acediffr-45780:OtherReportableSegmentMember457802025-01-012025-12-31jpcrp_cor:ReconcilingItemsMember457802024-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember457802024-12-31jpigp_cor:RetainedEarningsIFRSMember457802024-12-31jpigp_cor:TreasurySharesIFRSMember457802024-12-31jpigp_cor:CapitalSurplusIFRSMember457802024-12-31jpigp_cor:ShareCapitalIFRSMember457802024-01-012024-12-31jpigp_cor:NonControllingInterestsIFRSMember457802024-01-012024-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember457802024-01-012024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember457802024-01-012024-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember457802024-01-012024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember457802024-01-012024-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember457802024-01-012024-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember457802024-01-012024-12-31jpigp_cor:RetainedEarningsIFRSMember457802024-01-012024-12-31jpigp_cor:TreasurySharesIFRSMember457802024-01-012024-12-31jpigp_cor:CapitalSurplusIFRSMember457802024-01-012024-12-31jpigp_cor:ShareCapitalIFRSMember457802023-12-31jpigp_cor:NonControllingInterestsIFRSMember457802023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember457802023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember457802023-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember457802025-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember457802025-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember457802025-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember457802025-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember457802025-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember457802025-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember457802025-12-31jpigp_cor:RetainedEarningsIFRSMember457802025-12-31jpigp_cor:TreasurySharesIFRSMember457802025-12-31jpigp_cor:CapitalSurplusIFRSMember457802025-12-31jpigp_cor:ShareCapitalIFRSMember457802025-01-012025-12-31jpigp_cor:NonControllingInterestsIFRSMember457802025-01-012025-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember457802025-01-012025-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember457802025-01-012025-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember457802025-01-012025-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember457802025-01-012025-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember457802025-01-012025-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember457802025-01-012025-12-31jpigp_cor:RetainedEarningsIFRSMember457802025-01-012025-12-31jpigp_cor:TreasurySharesIFRSMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure